Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Guttmann OP"" wg kryterium: Autor


Tytuł :
The Safety and Feasibility of Transitioning From Transfemoral to Transradial Access Left Ventricular Endomyocardial Biopsy.
Autorzy :
Tyler Z
Guttmann OP
Dhinoja M
Oro R
Savvatis K
Mohiddin S
Sekhri N
Lopes L
Patel V
Jones DA
Bourantas CV
Mathur A
Elliott PM
O'Mahony C; St. Bartholomew's Hospital, W. Smithfield, London EC1A 7BE, United Kingdom. .
Pokaż więcej
Źródło :
The Journal of invasive cardiology [J Invasive Cardiol] 2020 Nov 10. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.
Autorzy :
Choudry FA; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Hamshere SM; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Rathod KS; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Akhtar MM; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Archbold RA; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom.
Guttmann OP; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Woldman S; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Jain AK; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Knight CJ; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Baumbach A; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Mathur A; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Jones DA; Department of Cardiology, Barts Heart Centre, St. Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2020 Sep 08; Vol. 76 (10), pp. 1168-1176. Date of Electronic Publication: 2020 Jul 14.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Coronary Thrombosis*/blood
Coronary Thrombosis*/diagnosis
Coronary Thrombosis*/etiology
Coronavirus Infections*/blood
Coronavirus Infections*/complications
Coronavirus Infections*/diagnosis
Coronavirus Infections*/epidemiology
Pandemics*
Pneumonia, Viral*/blood
Pneumonia, Viral*/complications
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/epidemiology
ST Elevation Myocardial Infarction*/epidemiology
ST Elevation Myocardial Infarction*/therapy
Fibrinolytic Agents/*therapeutic use
Percutaneous Coronary Intervention/*methods
Aged ; Betacoronavirus/isolation & purification ; C-Reactive Protein/analysis ; Comorbidity ; Coronary Angiography/methods ; Female ; Fibrin Fibrinogen Degradation Products/analysis ; Humans ; Lymphocyte Count/methods ; Male ; Middle Aged ; Outcome and Process Assessment, Health Care ; Patient Selection ; Severity of Illness Index ; Troponin T/blood
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Computed tomography cardiac angiography for planning invasive angiographic procedures in patients with previous coronary artery bypass grafting.
Autorzy :
Jones DA; Barts Interventional Group, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Castle EV
Beirne AM
Rathod KS
Treibel TA
Guttmann OP
Moon JC
Smith EJ
Bourantas CV
Davies LC
Wragg A
Pugliese F
Mathur A
Pokaż więcej
Źródło :
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2020 Feb 07; Vol. 15 (15), pp. e1351-e1357. Date of Electronic Publication: 2020 Feb 07.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Computed Tomography Angiography*
Coronary Artery Disease*
Coronary Angiography ; Coronary Artery Bypass ; Heart ; Humans ; Sensitivity and Specificity ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Pacemaker therapy for hypertrophic obstructive cardiomyopathy: unresolved contradictions between observational and randomized studies.
Autorzy :
Malcolmson JW; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London, UK.; The Heart Centre, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK.
Guttmann OP; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London, UK.; Institute of Cardiovascular Science, University College London, Gower Street, London, UK.
Pokaż więcej
Źródło :
European heart journal. Quality of care & clinical outcomes [Eur Heart J Qual Care Clin Outcomes] 2019 Oct 01; Vol. 5 (4), pp. 281-282.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Cardiomyopathy, Hypertrophic*
Pacemaker, Artificial*
Humans
Czasopismo naukowe
Tytuł :
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
Autorzy :
O'Mahony C; The Inherited Cardiac Diseases Unit, Barts Heart Centre, St Bartholomew's Hospital, London, UK.; UCL Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART).
Akhtar MM; The Inherited Cardiac Diseases Unit, Barts Heart Centre, St Bartholomew's Hospital, London, UK.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART).; UCL Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
Anastasiou Z; Department of Statistical Science, University College London, London, UK.
Guttmann OP; The Inherited Cardiac Diseases Unit, Barts Heart Centre, St Bartholomew's Hospital, London, UK.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART).; UCL Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
Vriesendorp PA; Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
Michels M; Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
Magrì D; Clinical and Molecular Medicine, University 'La Sapienza', Rome, Italy.
Autore C; Clinical and Molecular Medicine, University 'La Sapienza', Rome, Italy.
Fernández A; Department of Cardiology, Favaloro Foundation University Hospital, Institute of Cardiology and Cardiovascular Surgery, Buenos Aires, Argentina.
Ochoa JP; Department of Cardiology, Favaloro Foundation University Hospital, Institute of Cardiology and Cardiovascular Surgery, Buenos Aires, Argentina.; GRINCAR (Cardiovascular Research Group), University of A Coruña, A Coruña, Spain.; Scientific Department, Health In Code, A Coruña, Spain.
Leong KMW; Imperial College Healthcare NHS Trust, London, UK.
Varnava AM; Imperial College Healthcare NHS Trust, London, UK.
Monserrat L; Scientific Department, Health In Code, A Coruña, Spain.; Cardiology Department and Research Unit, A Coruña University Hospital, Galician Health Service, A Coruña, Spain.
Anastasakis A; Unit of Inherited Cardiovascular Diseases, First Department of Cardiology, University of Athens, Athens, Greece.
Garcia-Pavia P; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART).; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.; University Francisco de Vitoria (UFV), Madrid, Spain.; Centro de Investigacion Biomedica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Rapezzi C; Department of Specialised, Experimental and Diagnostic Medicine, Institute of Cardiology, University of Bologna, Bologna, Italy.
Biagini E; Department of Specialised, Experimental and Diagnostic Medicine, Institute of Cardiology, University of Bologna, Bologna, Italy.
Gimeno JR; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART).; Cardiac Department, University Hospital Virgen Arrixaca, La Alberca (Murcia), Spain.
Limongelli G; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART).; Monaldi Hospital, Second University of Naples, Naples, Italy.
Omar RZ; Department of Statistical Science, University College London, London, UK.
Elliott PM; The Inherited Cardiac Diseases Unit, Barts Heart Centre, St Bartholomew's Hospital, London, UK.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART).; UCL Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
Pokaż więcej
Źródło :
Heart (British Cardiac Society) [Heart] 2019 Apr; Vol. 105 (8), pp. 623-631. Date of Electronic Publication: 2018 Oct 26.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Cardiomyopathy, Hypertrophic*/complications
Cardiomyopathy, Hypertrophic*/diagnosis
Cardiomyopathy, Hypertrophic*/mortality
Death, Sudden, Cardiac*/etiology
Death, Sudden, Cardiac*/prevention & control
Risk Assessment/*methods
Data Accuracy ; Europe ; Humans ; Practice Guidelines as Topic ; Primary Prevention
Czasopismo naukowe
Tytuł :
Routine use of fluoroscopic guidance and up-front femoral angiography results in reduced femoral complications in patients undergoing coronary angiographic procedures: an observational study using an Interrupted Time-Series analysis.
Autorzy :
Castle EV; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.
Rathod KS; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London, UK.
Guttmann OP; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.
Jenkins AM; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.
McCarthy CD; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.
Knight CJ; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London, UK.
O'Mahony C; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.
Mathur A; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London, UK.
Smith EJ; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London, UK.
Weerackody R; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London, UK.
Timmis AD; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London, UK.
Wragg A; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK.; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London, UK.
Jones DA; Barts Interventional Group, Interventional Cardiology, Barts Heart Centre, St Bartholomew's Hospital, 2nd Floor, King George V Building, West Smithfield, London, EC1A 7BE, UK. .; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London, UK. .
Pokaż więcej
Źródło :
Heart and vessels [Heart Vessels] 2019 Mar; Vol. 34 (3), pp. 419-426. Date of Electronic Publication: 2018 Sep 27.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Coronary Angiography/*methods
Coronary Artery Disease/*surgery
Fluoroscopy/*methods
Percutaneous Coronary Intervention/*methods
Surgery, Computer-Assisted/*methods
Vascular System Injuries/*prevention & control
Aged ; Coronary Artery Disease/diagnosis ; Female ; Femoral Artery ; Follow-Up Studies ; Humans ; Incidence ; Male ; Prospective Studies ; Risk Factors ; Time Factors ; United Kingdom/epidemiology ; Vascular System Injuries/epidemiology
Czasopismo naukowe
Tytuł :
Atrial fibrillation and thromboembolism in hypertrophic cardiomyopathy - An underestimated risk.
Autorzy :
Guttmann OP; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, United Kingdom; Institute of Cardiovascular Science, University College London, Gower Street, London WC1E 6BT, United Kingdom. Electronic address: oliver.guttmann@bartshealth.nhs.uk.
Pokaż więcej
Źródło :
International journal of cardiology [Int J Cardiol] 2018 Dec 15; Vol. 273, pp. 187-188. Date of Electronic Publication: 2018 Sep 19.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Atrial Fibrillation*
Thromboembolism*
Cardiomyopathy, Hypertrophic ; Humans ; Incidence ; Prevalence ; Stroke
Opinia redakcyjna
Tytuł :
Risk scoring to guide antiplatelet therapy post-percutaneous coronary intervention for acute coronary syndrome results in improved clinical outcomes.
Autorzy :
Antoniou S; Department of Pharmacy, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Colicchia M; Department of Cardiology, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Guttmann OP; Department of Cardiology, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Rathod KS; Department of Cardiology, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Wright P; Department of Pharmacy, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Fhadil S; Department of Pharmacy, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Knight CJ; Department of Cardiology, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Jain AK; Department of Cardiology, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Smith EJ; Department of Cardiology, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Mathur A; Department of Cardiology, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Weerackody R; Department of Cardiology, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Wragg A; Department of Cardiology, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Jones DA; Department of Cardiology, Barts Health NHS Trust, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK.
Pokaż więcej
Źródło :
European heart journal. Quality of care & clinical outcomes [Eur Heart J Qual Care Clin Outcomes] 2018 Oct 01; Vol. 4 (4), pp. 283-289.
Typ publikacji :
Journal Article
MeSH Terms :
Percutaneous Coronary Intervention*
Practice Guidelines as Topic*
Acute Coronary Syndrome/*surgery
Platelet Aggregation Inhibitors/*therapeutic use
Postoperative Care/*standards
Postoperative Complications/*prevention & control
Risk Assessment/*methods
Acute Coronary Syndrome/diagnosis ; Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Middle Aged ; Postoperative Complications/epidemiology ; Prospective Studies ; Risk Factors ; Survival Rate/trends ; Treatment Outcome ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł :
Outcomes following the surgical management of left ventricular outflow tract obstruction; A systematic review and meta-analysis.
Autorzy :
Collis RA; Institute of Cardiovascular Science, University College London, Gower Street, London WC1E 6BT, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, United Kingdom.
Rahman MS; Institute of Statistical Research and Training (ISRT), University of Dhaka, Dhaka, Bangladesh.
Watkinson O; Institute of Cardiovascular Science, University College London, Gower Street, London WC1E 6BT, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, United Kingdom.
Guttmann OP; Institute of Cardiovascular Science, University College London, Gower Street, London WC1E 6BT, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, United Kingdom.
O'Mahony C; Institute of Cardiovascular Science, University College London, Gower Street, London WC1E 6BT, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, United Kingdom.
Elliott PM; Institute of Cardiovascular Science, University College London, Gower Street, London WC1E 6BT, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
International journal of cardiology [Int J Cardiol] 2018 Aug 15; Vol. 265, pp. 62-70.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Disease Management*
Heart Ventricles/*surgery
Ventricular Outflow Obstruction/*mortality
Ventricular Outflow Obstruction/*surgery
Heart Ventricles/pathology ; Humans ; Mortality/trends ; Treatment Outcome ; Ventricular Outflow Obstruction/diagnosis
Czasopismo naukowe
Tytuł :
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).
Autorzy :
O'Mahony C; St. Bartholomew's Centre for Inherited Cardiovascular Disease, St Bartholomew's Hospital, West Smithfield, London, United Kingdom (C.O., S.A.M., O.P.G., J.M., N.S., P.M.E.). .; Centre for Heart Muscle Disease, Institute of Cardiovascular Science (C.O., P.M.E.).; University College London, United Kingdom. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu) (C.O., I.C., P.G.-P., S.A.M., A.V., A.W., V.F., O.P.G., J.M., N.S., P.M.E.).
Jichi F; Biostatistics Group, University College London Hospitals/University College London Joint Research Office (F.J.).
Ommen SR; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (S.R.O., J.B.G., K.C.S., K.D.M.).
Christiaans I; University College London, United Kingdom. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu) (C.O., I.C., P.G.-P., S.A.M., A.V., A.W., V.F., O.P.G., J.M., N.S., P.M.E.).; Heart Center, Department of Clinical and Experimental Cardiology (I.C., A.V., A.W.).; Department of Clinical Genetics (I.C., A.V.).
Arbustini E; Academic Medical Center, Amsterdam, Netherlands. Centre for Inherited Cardiovascular Diseases, Transplant Research Area, Istituto di Ricovero e Cura a Carattere Scientifico Foundation, Policlinico San Matteo, Pavia, Italy (E.A., V.F.).
Garcia-Pavia P; University College London, United Kingdom. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu) (C.O., I.C., P.G.-P., S.A.M., A.V., A.W., V.F., O.P.G., J.M., N.S., P.M.E.).; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain (P.G.-P., M.G.-D., F.D.).; Centro de Investigacion Biomedica en Red en Enfermedades Cardiovasculares, Madrid, Spain (P.G.-P.). University Francisco de Vitoria, Pozuelo de Alarcón, Madrid, Spain (P.G.-P.).
Cecchi F; Department of Cardiology, Careggi University Hospital, Florence, Italy (F.C., I.O., I.T.).
Olivotto I; Department of Cardiology, Careggi University Hospital, Florence, Italy (F.C., I.O., I.T.).
Kitaoka H; Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku-shi, Japan (H.K., T.K.).
Gotsman I; Heart Institute, Hadassah University Hospital, Jerusalem, Israel (I.G., A.K.).
Carr-White G; Guy's and St. Thomas' Hospital National Health Service Foundation Trust, London, United Kingdom (G.C.-W., T.B., S.W.).
Mogensen J; London Chest Hospital, United Kingdom (S.A.M., J.M., T.B., N.S.).
Antoniades L; Inherited Cardiovascular Disease Unit, Department of Cardiology, Nicosia General Hospital, Latsia, Cyprus (L.A.).
Mohiddin SA; St. Bartholomew's Centre for Inherited Cardiovascular Disease, St Bartholomew's Hospital, West Smithfield, London, United Kingdom (C.O., S.A.M., O.P.G., J.M., N.S., P.M.E.).; University College London, United Kingdom. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu) (C.O., I.C., P.G.-P., S.A.M., A.V., A.W., V.F., O.P.G., J.M., N.S., P.M.E.).; London Chest Hospital, United Kingdom (S.A.M., J.M., T.B., N.S.).
Maurer MS; Columbia University Medical Center, New York, NY (M.S.M., C.W.H.).
Tang HC; Department of Cardiology, National Heart Centre Singapore (H.C.T.).
Geske JB; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (S.R.O., J.B.G., K.C.S., K.D.M.).
Siontis KC; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (S.R.O., J.B.G., K.C.S., K.D.M.).; Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (K.C.S.).
Mahmoud KD; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (S.R.O., J.B.G., K.C.S., K.D.M.).; Thorax Center, Department of Cardiology, Erasmus Medical Center, Rotterdam, Netherlands (K.D.M.).
Vermeer A; University College London, United Kingdom. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu) (C.O., I.C., P.G.-P., S.A.M., A.V., A.W., V.F., O.P.G., J.M., N.S., P.M.E.).; Heart Center, Department of Clinical and Experimental Cardiology (I.C., A.V., A.W.).; Department of Clinical Genetics (I.C., A.V.).
Wilde A; University College London, United Kingdom. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu) (C.O., I.C., P.G.-P., S.A.M., A.V., A.W., V.F., O.P.G., J.M., N.S., P.M.E.).; Heart Center, Department of Clinical and Experimental Cardiology (I.C., A.V., A.W.).
Favalli V; University College London, United Kingdom. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu) (C.O., I.C., P.G.-P., S.A.M., A.V., A.W., V.F., O.P.G., J.M., N.S., P.M.E.).; Academic Medical Center, Amsterdam, Netherlands. Centre for Inherited Cardiovascular Diseases, Transplant Research Area, Istituto di Ricovero e Cura a Carattere Scientifico Foundation, Policlinico San Matteo, Pavia, Italy (E.A., V.F.).
Guttmann OP; St. Bartholomew's Centre for Inherited Cardiovascular Disease, St Bartholomew's Hospital, West Smithfield, London, United Kingdom (C.O., S.A.M., O.P.G., J.M., N.S., P.M.E.).; The Inherited Cardiac Diseases Unit, The Heart Hospital (O.P.G., P.M.E.).; University College London, United Kingdom. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu) (C.O., I.C., P.G.-P., S.A.M., A.V., A.W., V.F., O.P.G., J.M., N.S., P.M.E.).
Gallego-Delgado M; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain (P.G.-P., M.G.-D., F.D.).
Dominguez F; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain (P.G.-P., M.G.-D., F.D.).
Tanini I; Department of Cardiology, Careggi University Hospital, Florence, Italy (F.C., I.O., I.T.).
Kubo T; Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku-shi, Japan (H.K., T.K.).
Keren A; Heart Institute, Hadassah University Hospital, Jerusalem, Israel (I.G., A.K.).; Clalit Health Services Beit Hadfus 20, Jerusalem, Israel (A.K.). Assuta Hospitals, Tel Aviv, Israel (A.K.).
Bueser T; London Chest Hospital, United Kingdom (S.A.M., J.M., T.B., N.S.).; King's College London, United Kingdom (T.B.). St George's, University of London, United Kingdom (T.B.).
Waters S; Guy's and St. Thomas' Hospital National Health Service Foundation Trust, London, United Kingdom (G.C.-W., T.B., S.W.).
Issa IF; Department of Cardiology, Odense University Hospital, Denmark (J.M., I.F.I.).
Malcolmson J; St. Bartholomew's Centre for Inherited Cardiovascular Disease, St Bartholomew's Hospital, West Smithfield, London, United Kingdom (C.O., S.A.M., O.P.G., J.M., N.S., P.M.E.).; University College London, United Kingdom. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu) (C.O., I.C., P.G.-P., S.A.M., A.V., A.W., V.F., O.P.G., J.M., N.S., P.M.E.).; Department of Cardiology, Odense University Hospital, Denmark (J.M., I.F.I.).
Burns T; Guy's and St. Thomas' Hospital National Health Service Foundation Trust, London, United Kingdom (G.C.-W., T.B., S.W.).
Sekhri N; St. Bartholomew's Centre for Inherited Cardiovascular Disease, St Bartholomew's Hospital, West Smithfield, London, United Kingdom (C.O., S.A.M., O.P.G., J.M., N.S., P.M.E.).; University College London, United Kingdom. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu) (C.O., I.C., P.G.-P., S.A.M., A.V., A.W., V.F., O.P.G., J.M., N.S., P.M.E.).; London Chest Hospital, United Kingdom (S.A.M., J.M., T.B., N.S.).
Hoeger CW; Columbia University Medical Center, New York, NY (M.S.M., C.W.H.).
Omar RZ; Department of Statistical Science (R.Z.O.).
Elliott PM; St. Bartholomew's Centre for Inherited Cardiovascular Disease, St Bartholomew's Hospital, West Smithfield, London, United Kingdom (C.O., S.A.M., O.P.G., J.M., N.S., P.M.E.).; Centre for Heart Muscle Disease, Institute of Cardiovascular Science (C.O., P.M.E.).; The Inherited Cardiac Diseases Unit, The Heart Hospital (O.P.G., P.M.E.).; University College London, United Kingdom. European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu) (C.O., I.C., P.G.-P., S.A.M., A.V., A.W., V.F., O.P.G., J.M., N.S., P.M.E.).
Pokaż więcej
Źródło :
Circulation [Circulation] 2018 Mar 06; Vol. 137 (10), pp. 1015-1023. Date of Electronic Publication: 2017 Nov 30.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Cardiology*
Cardiomyopathy, Hypertrophic/*epidemiology
Death, Sudden, Cardiac/*prevention & control
Cardiomyopathy, Hypertrophic/complications ; Cardiomyopathy, Hypertrophic/diagnosis ; Cohort Studies ; Death, Sudden, Cardiac/etiology ; Defibrillators, Implantable/statistics & numerical data ; Europe/epidemiology ; Follow-Up Studies ; Humans ; Incidence ; Practice Guidelines as Topic ; Prognosis ; Research Design ; Retrospective Studies ; Risk ; Societies, Medical
Czasopismo naukowe
Tytuł :
Long-term outcomes for different surgical strategies to treat left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
Autorzy :
Collis R; Institute of Cardiovascular Science, University College London, London, UK.; Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Watkinson O; Institute of Cardiovascular Science, University College London, London, UK.; Barts Heart Centre, St Bartholomew's Hospital, London, UK.
O'Mahony C; Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Guttmann OP; Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Pantazis A; Royal Brompton Hospital, Chelsea, London, UK.
Tome-Esteban M; Cardiology Clinical Academic Group, St George's University Hospitals NHS Foundation Trust, Tooting, London, UK.
Tsang V; Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Chandrasekaran V; Cardiology Clinical Academic Group, St George's University Hospitals NHS Foundation Trust, Tooting, London, UK.
McGregor CGA; Institute of Cardiovascular Science, University College London, London, UK.
Elliott PM; Institute of Cardiovascular Science, University College London, London, UK.; Barts Heart Centre, St Bartholomew's Hospital, London, UK.
Pokaż więcej
Źródło :
European journal of heart failure [Eur J Heart Fail] 2018 Feb; Vol. 20 (2), pp. 398-405. Date of Electronic Publication: 2017 Nov 16.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Practice Guidelines as Topic*
Cardiac Surgical Procedures/*methods
Cardiomyopathy, Hypertrophic/*surgery
Ventricular Outflow Obstruction/*surgery
Adult ; Cardiomyopathy, Hypertrophic/complications ; Cardiomyopathy, Hypertrophic/diagnosis ; Echocardiography ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Postoperative Complications/epidemiology ; Retrospective Studies ; Survival Rate/trends ; Time Factors ; Treatment Outcome ; United Kingdom/epidemiology ; Ventricular Outflow Obstruction/diagnosis ; Ventricular Outflow Obstruction/etiology
Czasopismo naukowe
Tytuł :
Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.
Autorzy :
Pujades-Rodriguez M; Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom.; Farr Institute of Health Informatics Research, Institute of Health Informatics, University College London, London, United Kingdom.
Guttmann OP; Institute for Cardiovascular Science, University College London Institute for Cardiovascular Science and Barts Heart Centre, St. Bartholomew's Hospital, St Bartholomew's Hospital, London, United Kingdom.
Gonzalez-Izquierdo A; Farr Institute of Health Informatics Research, Institute of Health Informatics, University College London, London, United Kingdom.
Duyx B; Farr Institute of Health Informatics Research, Institute of Health Informatics, University College London, London, United Kingdom.; CAPHRI School for Public Health and Primary Care, Maastricht University, Universiteitssingel, Maastricht, the Netherlands.
O'Mahony C; Institute for Cardiovascular Science, University College London Institute for Cardiovascular Science and Barts Heart Centre, St. Bartholomew's Hospital, St Bartholomew's Hospital, London, United Kingdom.
Elliott P; Institute for Cardiovascular Science, University College London Institute for Cardiovascular Science and Barts Heart Centre, St. Bartholomew's Hospital, St Bartholomew's Hospital, London, United Kingdom.
Hemingway H; Farr Institute of Health Informatics Research, Institute of Health Informatics, University College London, London, United Kingdom.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2018 Jan 11; Vol. 13 (1), pp. e0191214. Date of Electronic Publication: 2018 Jan 11 (Print Publication: 2018).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiomyopathy, Hypertrophic/*complications
Adult ; Aged ; Algorithms ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/mortality ; Cohort Studies ; Death, Sudden, Cardiac/etiology ; Electronic Health Records ; England ; Female ; Heart Failure/etiology ; Hemorrhage/etiology ; Humans ; Incidence ; Male ; Middle Aged ; Myocardial Infarction/etiology ; Risk Factors
Czasopismo naukowe
Tytuł :
Prevalence and outcomes of coronary artery perforation during percutaneous coronary intervention.
Autorzy :
Guttmann OP; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Jones DA
Gulati A
Kotecha T
Fayed H
Patel D
Crake T
Ozkor M
Wragg A
Smith EJ
Weerackody R
Knight CJ
Mathur A
O'Mahony C
Pokaż więcej
Źródło :
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2017 Aug 04; Vol. 13 (5), pp. e595-e601. Date of Electronic Publication: 2017 Aug 04.
Typ publikacji :
Journal Article
MeSH Terms :
Coronary Artery Disease/*epidemiology
Coronary Vessels/*physiopathology
Percutaneous Coronary Intervention/*adverse effects
Aged ; Angioplasty, Balloon, Coronary/methods ; Coronary Angiography/methods ; Coronary Artery Disease/etiology ; Drug-Eluting Stents ; Female ; Heart Injuries/epidemiology ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention/methods ; Prevalence ; Risk Factors ; Thrombosis/epidemiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Predictors of atrial fibrillation in hypertrophic cardiomyopathy.
Autorzy :
Guttmann OP; University College London Institute for Cardiovascular Science and Barts Heart Centre, St. Bartholomew's Hospital, London, UK.
Pavlou M; Department of Statistical Science, University College London, London, UK.
O'Mahony C; University College London Institute for Cardiovascular Science and Barts Heart Centre, St. Bartholomew's Hospital, London, UK.
Monserrat L; Cardiology Department and Research Unit, A Coruña University Hospital, Galician Health Service, Spain.
Anastasakis A; Unit of Inherited Cardiovascular Diseases, First Department of Cardiology, University of Athens, Athens, Greece.
Rapezzi C; Department of Specialised, Experimental and Diagnostic Medicine, Institute of Cardiology, University of Bologna, Bologna, Italy.
Biagini E; Department of Specialised, Experimental and Diagnostic Medicine, Institute of Cardiology, University of Bologna, Bologna, Italy.
Gimeno JR; Cardiac Department, University Hospital Virgen ArrixacaMurcia, Spain.
Limongelli G; Monaldi Hospital, Second University of Naples, Naples, Italy.
Garcia-Pavia P; Heart Failure and Inherited Cardiac Diseases Unit, Hospital Universitario Puerta del Hierro Majadahonda, Madrid, Spain.
McKenna WJ; University College London Institute for Cardiovascular Science and Barts Heart Centre, St. Bartholomew's Hospital, London, UK.
Omar RZ; Department of Statistical Science, University College London, London, UK.; Biostatistics Group, University College London Hospitals/University College London Clinical Research Centre, University College London, London, UK.
Elliott PM; University College London Institute for Cardiovascular Science and Barts Heart Centre, St. Bartholomew's Hospital, London, UK.
Pokaż więcej
Corporate Authors :
Hypertrophic Cardiomyopathy Outcomes Investigators
Źródło :
Heart (British Cardiac Society) [Heart] 2017 May; Vol. 103 (9), pp. 672-678. Date of Electronic Publication: 2016 Oct 28.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Heart Rate*/drug effects
Atrial Fibrillation/*epidemiology
Cardiomyopathy, Hypertrophic/*epidemiology
Heart Conduction System/*physiopathology
Action Potentials ; Adult ; Aged ; Anti-Arrhythmia Agents/therapeutic use ; Atrial Fibrillation/mortality ; Atrial Fibrillation/physiopathology ; Atrial Fibrillation/prevention & control ; Cardiomyopathy, Hypertrophic/drug therapy ; Cardiomyopathy, Hypertrophic/mortality ; Cardiomyopathy, Hypertrophic/physiopathology ; Electrocardiography, Ambulatory ; Europe/epidemiology ; Female ; Heart Conduction System/drug effects ; Humans ; Incidence ; Kaplan-Meier Estimate ; Longitudinal Studies ; Male ; Middle Aged ; Multivariate Analysis ; Prevalence ; Propensity Score ; Proportional Hazards Models ; Protective Factors ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm.
Autorzy :
Guttmann OP; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Jones DA; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London - UK; NIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Safwan KA; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Gallagher S; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Rathod KS; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London - UK; NIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Hamshere S; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London - UK; NIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Smith EJ; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Jain AK; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London - UK; NIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Mathur A; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University, London - UK; NIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Wragg A; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK; NIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Knight CJ; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK; NIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Weerackody R; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London - UK; NIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, Barts Health NHS Trust, London - UK.
Pokaż więcej
Źródło :
Heart international [Heart Int] 2016 May 12; Vol. 11 (1), pp. e17-e24. Date of Electronic Publication: 2016 May 12 (Print Publication: 2016).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA).
Autorzy :
Guttmann OP; The Inherited Cardiac Diseases Unit, The Heart Hospital/University College London, London, UK.
Pavlou M; Department of Statistical Science, University College London, London, UK.
O'Mahony C; The Inherited Cardiac Diseases Unit, The Heart Hospital/University College London, London, UK.
Monserrat L; Cardiology Department and Research Unit, A Coruña University Hospital, Galician Health Service, Spain.
Anastasakis A; Unit of Inherited Cardiovascular Diseases, 1st Department of Cardiology, University of Athens, Athens, Greece.
Rapezzi C; Institute of Cardiology, Department of Specialised, Experimental and Diagnostic Medicine, University of Bologna, Bologna, Italy.
Biagini E; Institute of Cardiology, Department of Specialised, Experimental and Diagnostic Medicine, University of Bologna, Bologna, Italy.
Gimeno JR; Cardiac Department, University Hospital Virgen Arrixaca, Murcia-Cartagena s/n, El Palmar, Murcia, Spain.
Limongelli G; Monaldi Hospital, Second University of Naples, Naples, Italy.
Garcia-Pavia P; Heart Failure and Inherited Cardiac Diseases Unit, Hospital Universitario Puerta del Hierro Majadahonda, Madrid, Spain.
McKenna WJ; The Inherited Cardiac Diseases Unit, The Heart Hospital/University College London, London, UK.
Omar RZ; Department of Statistical Science, University College London, London, UK.; Biostatistics Group, University College London Hospitals/University College London Clinical Research Centre, University College London, London, UK.
Elliott PM; The Inherited Cardiac Diseases Unit, The Heart Hospital/University College London, London, UK.
Pokaż więcej
Corporate Authors :
Hypertrophic Cardiomyopathy Outcomes Investigators
Źródło :
European journal of heart failure [Eur J Heart Fail] 2015 Aug; Vol. 17 (8), pp. 837-45. Date of Electronic Publication: 2015 Jul 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiomyopathy, Hypertrophic/*complications
Thromboembolism/*etiology
Age Factors ; Anticoagulants/therapeutic use ; Atrial Fibrillation/drug therapy ; Atrial Fibrillation/physiopathology ; Cohort Studies ; Female ; Heart Atria/pathology ; Humans ; Longitudinal Studies ; Male ; Models, Theoretical ; Proportional Hazards Models ; Retrospective Studies ; Thromboembolism/prevention & control ; Vitamin K/antagonists & inhibitors
Czasopismo naukowe
Tytuł :
Almanac 2014: cardiomyopathies.
Autorzy :
Guttmann OP; Inherited Cardiac Diseases Unit, The Heart Hospital, University College London, London, UK.
Mohiddin SA; Department of Cardiology, The London Chest Hospital, London, UK.
Elliott PM; Inherited Cardiac Diseases Unit, The Heart Hospital, University College London, London, UK.
Pokaż więcej
Źródło :
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir [Turk Kardiyol Dern Ars] 2015 Apr; Vol. 43 (3), pp. 302-14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Cardiomyopathies/*diagnosis
Cardiomyopathies/*therapy
Humans
Czasopismo naukowe
Tytuł :
Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.
Autorzy :
Lopes LR; UCL Institute of Cardiovascular Science, London, UK.
Syrris P; UCL Institute of Cardiovascular Science, London, UK.
Guttmann OP; UCL Institute of Cardiovascular Science, London, UK.
O'Mahony C; UCL Institute of Cardiovascular Science, London, UK The London Chest Hospital, London, UK.
Tang HC; UCL Institute of Cardiovascular Science, London, UK National Heart Centre, Singapore, Singapore.
Dalageorgou C; UCL Institute of Cardiovascular Science, London, UK.
Jenkins S; UCL Institute of Cardiovascular Science, London, UK.
Hubank M; UCL Genomics, Department of Molecular Haematology and Cancer Biology, UCL Institute of Child Health, London, UK.
Monserrat L; Instituto de Investigación Biomédica de la Universidad de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC)-Universidad de A Coruña, A Coruña, Spain.
McKenna WJ; UCL Institute of Cardiovascular Science, London, UK.
Plagnol V; UCL Genetics Institute, London, UK.
Elliott PM; UCL Institute of Cardiovascular Science, London, UK.
Pokaż więcej
Źródło :
Heart (British Cardiac Society) [Heart] 2015 Feb; Vol. 101 (4), pp. 294-301. Date of Electronic Publication: 2014 Oct 28.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
High-Throughput Nucleotide Sequencing*
Mutation*
Cardiomyopathy, Hypertrophic, Familial/*genetics
DNA Mutational Analysis/*methods
Muscle Proteins/*genetics
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Cardiomyopathy, Hypertrophic, Familial/diagnosis ; Cardiomyopathy, Hypertrophic, Familial/mortality ; Child ; Death, Sudden, Cardiac/etiology ; Female ; Genetic Association Studies ; Genetic Predisposition to Disease ; Humans ; Kaplan-Meier Estimate ; London ; Male ; Middle Aged ; Pedigree ; Phenotype ; Predictive Value of Tests ; Retrospective Studies ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Almanac 2014: cardiomyopathies.
Autorzy :
Guttmann OP; Inherited Cardiac Diseases Unit, The Heart Hospital, University College London, , London, UK.
Mohiddin SA
Elliott PM
Pokaż więcej
Źródło :
Heart (British Cardiac Society) [Heart] 2014 May; Vol. 100 (10), pp. 756-64. Date of Electronic Publication: 2014 Mar 06.
Typ publikacji :
Journal Article; Meta-Analysis; Review
MeSH Terms :
Cardiomyopathies*/diagnosis
Cardiomyopathies*/epidemiology
Cardiomyopathies*/genetics
Diagnostic Imaging/*methods
Genetic Testing/*methods
Electrocardiography ; Genetic Predisposition to Disease ; Global Health ; Humans ; Morbidity/trends ; Prognosis ; Survival Rate/trends
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies